Package 50090-6310-0

Brand: chlordiazepoxide hydrochloride and clidinium bromide

Generic: chlordiazepoxide hydrochloride and clidinium bromide
NDC Package

Package Facts

Identity

Package NDC 50090-6310-0
Digits Only 5009063100
Product NDC 50090-6310
Description

30 CAPSULE in 1 BOTTLE (50090-6310-0)

Marketing

Marketing Status
Marketed Since 2023-01-03
Brand chlordiazepoxide hydrochloride and clidinium bromide
Generic chlordiazepoxide hydrochloride and clidinium bromide
Sample Package No

Linked Drug Pages (0)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "44a52833-81d0-4b4a-8f7b-e863b94af466", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["883efb7c-7ab2-434b-9094-5a620375b6d2"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-6310-0)", "package_ndc": "50090-6310-0", "marketing_start_date": "20230103"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "50090-6310_44a52833-81d0-4b4a-8f7b-e863b94af466", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "50090-6310", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA214698", "marketing_category": "ANDA", "marketing_start_date": "20210510", "listing_expiration_date": "20261231"}